Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Montelukast for pain in erosive hand osteoarthritis
2021-001465-20Phase 3Suspended
- Sponsor
- Farmalíder
- Start
- Oct 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in hand osteoarthritis comparing Montelukast arm with Placebo arm (2 arms). Primary endpoint: Primary: pain intensity difference vs baseline at 24 weeks. Started Oct 2021; status: suspended.
02
Drugs
montelukast
03
Conditions
hand osteoarthritis
Beyond the preview
Go deeper on 2021-001465-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-001465-20.